Corcept (CORT) Class Action Alleges Misstatements on FDA Data Concerns - Hagens Berman
PR Newswire —
SAN FRANCISCO, April 1, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) that the deadline to move for Lead Plaintiff in the pending securities class action is April 21, 2026. The firm urges...